TScan Teams Up With Qiagen On T Cell COVID-19 Test
A new deal gives Qiagen the option to license T cell-based COVID-19 tests based on the T cell receptor targets identified with TScan’s technology.
You may also be interested in...
Antibody Testing During And After The Pandemic: Not All Tests Are Created Equal
While the main role of SARS-CoV-2 antibody testing is currently limited to determining exposure to the virus in populations, the scientific community is working hard to define the neutralizing properties of the antibodies detected, and the duration of the immune response. As a result, antibody testing could be here to stay for the long term for monitoring populations, testing vaccines and selecting patients for trials of a variety of new therapies to treat numerous conditions.
Minute Insight: Bayer Launches Precision Health Unit To Focus On Digital Consumer Health
The pharma giant said the new division will help people take control of their own health care with digital products.
Medtronic Creates Chief Technology And Innovation Officer Role
Ken Washington, the former general manager of consumer robotics, will help the company “accelerate innovation-driven growth.”